Brecanavir (INN; codenamed GW640385) is a protease inhibitor which has been studied for the treatment of HIV.
Brecanavir (INN; codenamed GW640385) is a protease inhibitor which has been studied for the treatment of HIV.
In December 2006, its developer, GlaxoSmithKline discontinued further development because of insurmountable issues regarding formulation.
Discovered by embedding cosine similarity (sentence-transformers MiniLM, 384-dim).